Newsfeeds - Spark Newswire

2 minute read

TELA Bio And Next Science Enter Into Exclusive Distribution Agreement In The Plastic Reconstructive Market For Advanced Anti-Biofilm Surgical Wash

Today, 3:11 AM

TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue

TELA

2 minute read

Earnings

How Bad Are TELA Bio’s Earnings? | Return On Capital Employed

By Benzinga Insights

Today, 3:11 AM

TELA Bio (NASDAQ:TELA) brought in sales totaling $7.56 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 0.58%, resulting in a loss of $7.31 million.

TELA

2 minute read

TELA Bio Appoints Roberto Cuca As Chief Operating Officer And Chief Financial Officer

By Benzinga Newsdesk

Today, 3:11 AM

TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue

TELA

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

By Shanthi Rexaline

Today, 3:11 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

ABCL

1 minute read

Earnings

TELA Bio: Q2 Earnings Insights

By Benzinga Insights

Today, 3:11 AM

Shares of TELA Bio (NASDAQ:TELA) decreased 2.3% after the company reported Q2 results. Quarterly Results Earnings per share decreased 7.55% over the past year to ($0.57), which missed the estimate of ($0.52).

TELA

1 minute read

TELA Bio Q2 EPS $(0.57) Misses $(0.52) Estimate, Sales $7.56M Beat $6.31M Estimate

By Benzinga Newsdesk

Today, 3:11 AM

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.52) by 9.62 percent. This is a 7.55 percent decrease over losses of $(0.53) per share from the same

TELA

5 minute read

The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

By Shanthi Rexaline

Today, 3:11 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)

ACAD

11 minute read

Earnings Scheduled For August 11, 2021

By Benzinga Insights

Today, 3:11 AM

Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter.

ACVA

2 minute read

Earnings

Earnings Outlook For TELA Bio

By Benzinga Insights

Today, 3:11 AM

On Wednesday, August 11, TELA Bio (NASDAQ:TELA) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

TELA

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 3:11 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL